疾管署接管賽諾菲公司自費四價流感疫苗,致該公司無法依約交貨予醫療機構
Past 31 days
Total Visit: 0
There is 1 fact-checking reply to the message
Lin mark this message contains misinformation
originally written by Lin
替換之四價疫苗與先前進口之自費四價疫苗「無關」:經積極與賽諾菲公司協商,該公司同意以最快可供貨之24.3萬劑流感疫苗替換,因為該公司尚餘之三價流感疫苗數量不足,故部分以四價流感疫苗替換之,但該替換之四價疫苗與先前進口之自費四價疫苗無關。

References

https://www.mohw.gov.tw/cp-17-45356-1.html

The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.

Add Cofacts as friend in LINE
Add Cofacts as friend in LINE
LINE 機器人
查謠言詐騙